JPMORGAN CHASE & CO - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464950. A total of 4 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2021$7,020,000
+46.2%
1,000,0000.0%0.00%0.0%
Q4 2020$4,800,000
-32.5%
1,000,000
-16.5%
0.00%0.0%
Q3 2020$7,113,000
+473.2%
1,197,500
+551.5%
0.00%
Q2 2020$1,241,000
-52.9%
183,800
-55.6%
0.00%
-100.0%
Q1 2020$2,633,000
+8.2%
414,000
+77.5%
0.00%
Q4 2019$2,433,000
+3101.3%
233,300
+1102.6%
0.00%
Q3 2019$76,000
-98.6%
19,400
-93.7%
0.00%
-100.0%
Q4 2018$5,568,000
+22.5%
310,000
+210.0%
0.00%0.0%
Q2 2018$4,547,000
+47.2%
100,000
+70.9%
0.00%0.0%
Q1 2018$3,089,000
-69.1%
58,500
-88.8%
0.00%
-66.7%
Q1 2016$9,999,000
+5613.7%
520,800
+10316.0%
0.00%
Q4 2015$175,000
-62.0%
5,0000.0%0.00%
Q3 2015$460,0005,0000.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
Antara Capital LP 42,500$204,0000.04%
GROUP ONE TRADING, L.P. 866,700$4,160,0000.01%
JPMORGAN CHASE & CO 1,000,000$4,800,0000.00%
SIMPLEX TRADING, LLC 904$433,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLOVIS ONCOLOGY INC shareholders